Autoimmune Diseases and HIV
Immune system diseases get up while acquired autoimmunity improvement to pathogenic autoimmunity. Hereditary components notwithstanding ecological reasons direct this turn of events. The global commercial center length of Autoimmune Disease Therapeutics was $109,833 million of every 2017 and is anticipated to reach $153,320 million with the guide of utilizing the surrender of 2025, with a CAGR of 4.2 18-2025.
Related Conference of Autoimmune Diseases and HIV
December 21-22, 2026
7th World Congress on Neuroimmunology and Neuroinfectious Diseases
Paris, France
Autoimmune Diseases and HIV Conference Speakers
Recommended Sessions
- Autoimmune Diseases and HIV
- Hematopoietic, Lymphoid Malignancies and Immune System Development
- Immune Disorder
- Immune Response Regulation
- Immune Response Regulation
- Immune System and Immunology
- Immunization and Vaccination
- Immunogenetics
- Immunoresearch and Immunotechnology
- Microbial Parasitic and Fungal Immunology
- Mucosal and local Immunology
- NeuroImmunology
- OncoImmunology
- Stem Cells Immunology
- Technological Innovations in Immunology
- Therapeutic methods to autoimmunity
- Thyroid Autoimmunity
- Transplantation and Computational Immunology
- Vaccines and Immunotherapy
- Viral Immunology
Related Journals
Are you interested in
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (France)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (France)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (France)